FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dan-Arin Silasi

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ming Liu; Gil Mor; David L Rimm; Thomas Rutherford; Ayesha Alvero; Huan Cheng; Jennie Holmberg; Pei Hui; Xue Xiang; Gang Yin; Dan-Arin Silasi
High Frequency of Putative Ovarian Cancer Stem Cells With CD44/CK19 Coexpression Is Associated With Decreased Progression-Free Intervals In Patients With Recurrent Epithelial Ovarian Cancer.
Michelle A Glasgow; Thomas J Rutherford; Alessandro D Santin; Dan-Arin Silasi; Herbert Yu; Masoud Azodi; Peter E Schwartz
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
G Yin; Ayesha B Alvero; I Chefetz-Menaker; V Craveiro; Han-Hsuan Fu; J C Holmberg; M K Montagna; S Nuti; M Rossi; Thomas Rutherford; Dan-Arin Silasi; Y Yang; Gil Mor
Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dan-Arin Silasi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ming Liu; Gil Mor; David L Rimm; Thomas Rutherford; Ayesha Alvero; Huan Cheng; Jennie Holmberg; Pei Hui; Xue Xiang; Gang Yin; Dan-Arin Silasi
High Frequency of Putative Ovarian Cancer Stem Cells With CD44/CK19 Coexpression Is Associated With Decreased Progression-Free Intervals In Patients With Recurrent Epithelial Ovarian Cancer.
Reproductive sciences (Thousand Oaks, Calif.) 2013;20(5):605-15.
2013: Michelle A Glasgow; Thomas J Rutherford; Alessandro D Santin; Dan-Arin Silasi; Herbert Yu; Masoud Azodi; Peter E Schwartz
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
Journal of surgical oncology 2013;107(2):195-200.
2013: G Yin; Ayesha B Alvero; I Chefetz-Menaker; V Craveiro; Han-Hsuan Fu; J C Holmberg; M K Montagna; S Nuti; M Rossi; Thomas Rutherford; Dan-Arin Silasi; Y Yang; Gil Mor
Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential.
Oncogene 2013;32(1):39-49.
2012: Kurt E Roberts; Dan-Arin Silasi; Robert L Bell; Andrew J Duffy
Pure transvaginal laparoscopic appendectomy.
Surgical endoscopy 2012;26(11):3316.
2012: Shabnam Kashani; Anita Sargent; Dan-Arin Silasi; Karim Elsahwi; Taryn Gallo; Masoud Azodi
Vaginal cuff dehiscence in robotic-assisted total hysterectomy.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2012;16(4):530-6.
2012: Daniel Solomon; Robert L Bell; Andrew J Duffy; Amir H Shariff; Dan-Arin Silasi; Kurt E Roberts
Transvaginal cholecystectomy versus single-incision laparoscopic cholecystectomy versus four-port laparoscopic cholecystectomy: a prospective cohort study.
Surgical endoscopy 2012;26(10):2823-7.
2012: Kurt E Roberts; Amir Hafeez Shariff; Shohan Shetty; Dan-Arin Silasi; Andrew J Duffy; Robert L Bell
Transvaginal NOTES hybrid cholecystectomy.
Surgical innovation 2012;19(3):230-5.
2012: Taryn Gallo; Shabnam Kashani; Divya A Patel; Dan-Arin Silasi; Karim Elsahwi; Masoud Azodi
Robotic-assisted laparoscopic hysterectomy: outcomes in obese and morbidly obese patients.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2012;16(3):421-7.
2012: Stefania Bellone; I Bortolomai; N Buza; E Cocco; S Gasparrini; Sergio Pecorelli; E Ratner; D Roque; Thomas Rutherford; M Abu-Khalaf; Masoud Azodi; Peter E Schwartz; Dan-Arin Silasi; Alessandro D Santin
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
British journal of cancer 2012;106(9):1543-50.
2012: Karim S El-Sahwi; Jessica L Illuzzi; Elena S Ratner; Thomas J Rutherford; Masoud Azodi; Nina Carusillo; Peter E Schwartz; Dan-Arin Silasi; Joyce Varughese; Alessandro D Santin
A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.
Gynecologic oncology 2012;124(3):471-3.
2012: Kurt E Roberts; Tom Rutherford; Dan-Arin Silasi; Daniel Solomon; Andrew J Duffy; Walter E Longo; Tamar Mirensky; Robert L Bell
Pure transvaginal appendectomy versus traditional laparoscopic appendectomy for acute appendicitis: a prospective cohort study.
Annals of surgery 2012;255(2):266-9.
2012: Karim S ElSahwi; Taryn N Gallo; Charlene Hooper; Elena Ratner; Thomas J Rutherford; Alessandro D Santin; Peter E Schwartz; Dan-Arin Silasi; Maria C De Leon; Masoud Azodi
Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer.
Gynecologic oncology 2012;124(2):260-4.
2011: Karim S Elsahwi; Jessica L Illuzzi; Elena Ratner; Masoud Azodi; Emma Barber; Natalia Buza; Alessandro D Santin; Peter E Schwartz; Dan-Arin Silasi; Thomas J Rutherford
The significance of perineural invasion in early-stage cervical cancer.
Gynecologic oncology 2011;123(3):561-4.
2011: Joyce Varughese; Peter E Schwartz; Dan-Arin Silasi; Masoud Azodi; Stefania Bellone; Natalia Buza; Emiliano Cocco; Sergio Pecorelli; Elena Ratner; Thomas J Rutherford; Alessandro D Santin
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.
American journal of obstetrics and gynecology 2011;205(6):567.e1-7.
2011: P Todeschini; J Varughese; Peter E Schwartz; Dan-Arin Silasi; Masoud Azodi; Stefania Bellone; N Buza; L Carrara; E Cocco; F Guzzo; Pei Hui; K Lin; Sergio Pecorelli; E Ratner; Thomas Rutherford; Alessandro D Santin
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.
British journal of cancer 2011;105(8):1176-82.
2011: Emiliano Cocco; Ken-Yu Lin; Charles J Lockwood; Sergio Pecorelli; Thomas J Rutherford; Masoud Azodi; Marta Bellone; Stefania Bellone; Natalia Buza; Luisa Carrara; Peter E Schwartz; Dan-Arin Silasi; Renata Tassi; Paola Todeschini; Joyce Varughese; Alessandro D Santin
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Clinical & experimental metastasis 2011;28(7):689-700.
2011: Aliza L Leizer; Ayesha B Alvero; Han-Hsuan Fu; Jennie C Holmberg; Yung-Chi Cheng; Dan-Arin Silasi; Thomas Rutherford; Gil Mor
Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells.
American journal of reproductive immunology (New York, N.Y. : 1989) 2011;65(4):438-47.
2011: Rhoda Raji; Elena Ratner; Thomas J Rutherford; Peter Schwartz; Dan-Arin Silasi; Paola Todeschini; Joyce Varughese; Masoud Azodi; Stefania Bellone; Marta Betti; Natalia Buza; Luisa Carrara; Emiliano Cocco; Sara Gasparrini; Federica Guzzo; Sergio Pecorelli; Alessandro D Santin
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
Journal of experimental & clinical cancer research : CR 2011;30():106.
2011: Karina Dahl Steffensen; Marianne Waldstrøm; Yang Yang; Thomas Rutherford; Dan-Arin Silasi; Ayesha B Alvero; Jennie C Holmberg; Pei Hui; Anders Jakobsen; Gil Mor
Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.
Journal of oncology 2011;2011():620523.
2011: Emiliano Cocco; Michelle Glasgow; Charles J Lockwood; Sergio Pecorelli; Thomas J Rutherford; Masoud Azodi; Marta Bellone; Stefania Bellone; Natalia Buza; Luisa Carrara; Peter E Schwartz; Dan-Arin Silasi; Paola Todeschini; Joyce Varughese; Alessandro D Santin
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
BMC cancer 2011;11():263.
2010: Christine E Richter; Emiliano Cocco; Stefania Bellone; Marta Bellone; Francesca Casagrande; Paola Todeschini; Dominik Rüttinger; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(9):1440-7.
2010: Christine E Richter; Emiliano Cocco; Stefania Bellone; Dan-Arin Silasi; Dominik Rüttinger; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
American journal of obstetrics and gynecology 2010;203(6):582.e1-7.
2010: E Cocco; Zhiwei Hu; C E Richter; Stefania Bellone; F Casagrande; M Bellone; P Todeschini; G Krikun; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; N Buza; Sergio Pecorelli; C J Lockwood; Alessandro D Santin
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.
British journal of cancer 2010;103(6):812-9.
2010: Christine E Richter; Pei Hui; Natalia Buza; Dan-Arin Silasi; Masoud Azodi; Alessandro D Santin; Peter E Schwartz; Thomas Rutherford
HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
Journal of clinical pathology 2010;63(6):544-7.
2010: K El-Sahwi; Stefania Bellone; E Cocco; M Cargnelutti; F Casagrande; M Bellone; M Abu-Khalaf; N Buza; Fattaneh A Tavassoli; Pei Hui; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.
British journal of cancer 2010;102(1):134-43.
2010: Karim El-Sahwi; Stefania Bellone; Emiliano Cocco; Francesca Casagrande; Marta Bellone; Maysa Abu-Khalaf; Natalia Buza; Fattaneh A Tavassoli; Pei Hui; Dominik Rüttinger; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
Molecular cancer therapeutics 2010;9(1):57-66.
2009: Ayesha B Alvero; Han-Hsuan Fu; Jennie Holmberg; Irene Visintin; Liora Mor; Carlos Cano Marquina; Jessica Oidtman; Dan-Arin Silasi; Gil Mor
Stem-like ovarian cancer cells can serve as tumor vascular progenitors.
Stem cells (Dayton, Ohio) 2009;27(10):2405-13.
2009: E Cocco; Stefania Bellone; K El-Sahwi; M Cargnelutti; F Casagrande; N Buza; Fattaneh A Tavassoli; Eric Siegel; Irene Visintin; E Ratner; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.
British journal of cancer 2009;101(2):335-41.
2009: Stefania Bellone; Eric Siegel; Emiliano Cocco; Marilisa Cargnelutti; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(5):860-6.
2009: Stefania Bellone; Karim El-Sahwi; Emiliano Cocco; Francesca Casagrande; Marilisa Cargnelutti; Michela Palmieri; Eliana Bignotti; Chiara Romani; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Alessandro D Santin
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Journal of virology 2009;83(13):6779-89.
2009: Dan-Arin Silasi; Ayesha B Alvero; Thomas Rutherford; David Brown; Gil Mor
Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs.
Expert opinion on pharmacotherapy 2009;10(6):1059-67.
2009: Stefania Bellone; Simone Anfossi; Timothy J O'Brien; Martin J Cannon; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Cancer 2009;115(4):800-11.
2009: Eve M Bernstein; Alison Tate; Dan-Arin Silasi; Thomas Rutherford
Benign multicystic mesothelioma: a case report of three sisters.
Rare tumors 2009;1(2):e46.
2009: Ayesha B Alvero; Rui Chen; Han-Hsuan Fu; Michele Montagna; Peter E Schwartz; Thomas Rutherford; Dan-Arin Silasi; Karina D Steffensen; Marianne Waldstrom; Irene Visintin; Gil Mor
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.
Cell cycle (Georgetown, Tex.) 2009;8(1):158-66.
2009: Stefania Bellone; Simone Anfossi; Timothy J O'Brien; Martin J Cannon; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas Rutherford; Sergio Pecorelli; Alessandro D Santin
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
American journal of obstetrics and gynecology 2009;200(1):75.e1-10.
2008: Rui Chen; Ayesha B Alvero; Dan-Arin Silasi; Michael G Kelly; Stefan Fest; Irene Visintin; A Leiser; Peter E Schwartz; Thomas Rutherford; Gil Mor
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.
Oncogene 2008;27(34):4712-23.
2008: Rui Chen; Ayesha B Alvero; Dan-Arin Silasi; K D Steffensen; Gil Mor
Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
Oncogene 2008;27(2):225-33.
2008: Dan-Arin Silasi; Ayesha B Alvero; Jechiel Mor; Rui Chen; Han-Hsuan Fu; Michele K Montagna; Gil Mor
Detection of cancer-related proteins in fresh-frozen ovarian cancer samples using laser capture microdissection.
Methods in molecular biology (Clifton, N.J.) 2008;414():35-45.
2008: Dan-Arin Silasi; Jessica L Illuzzi; Michael G Kelly; Thomas Rutherford; Gil Mor; Masoud Azodi; Peter E Schwartz
Carcinosarcoma of the ovary.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(1):22-9.
2007: Rui Chen; Ayesha B Alvero; Dan-Arin Silasi; Gil Mor
Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
American journal of reproductive immunology (New York, N.Y. : 1989) 2007;57(2):93-107.
2006: Dan-Arin Silasi; Ayesha B Alvero; Jessica Illuzzi; Michael Kelly; Rui Chen; Han-Hsuan Fu; Peter Schwartz; Thomas Rutherford; Masoud Azodi; Gil Mor
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.
The Yale journal of biology and medicine 2006;79(3-4):153-63.
2006: Michael G Kelly; Ayesha B Alvero; Rui Chen; Dan-Arin Silasi; Vikki M Abrahams; Serena Chan; Irene Visintin; Thomas Rutherford; Gil Mor
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.
Cancer research 2006;66(7):3859-68.